Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 183

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs

Open access
Ranoa, Diana Rose E., Parekh, Akash D., Pitroda, Sean P., Huang, Xiaona, Darga, Thomas, Wong, Anthony C., Huang, Lei, Andrade, Jorge, Staley, Jonathan P., Satoh, Takashi, Akira, Shizuo, Weichselbaum, Ralph R., Khodarev, Nikolai N.·2016·Oncotarget

Abstract

// Diana Rose E. Ranoa 1 , Akash D. Parekh 1 , Sean P. Pitroda 1 , Xiaona Huang 1 , Thomas Darga 1,† , Anthony C. Wong 1 , Lei Huang 2 , Jorge Andrade 2 , Jonathan P. Staley 3 , Takashi Satoh 4 , Shizuo Akira 4 , Ralph R. Weichselbaum 1, * , Nikolai N. Khodarev 1, * 1 Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL 60637, USA 2 Center for Research Informatics, Biological Sciences Division, The University of Chicago, Chicago, IL 60637, USA 3 Department of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL 60637, USA 4 Laboratory of Host Defense, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan * These authors have contributed equally to this work † Deceased Correspondence to: Ralph R. Weichselbaum, email: rrw@radonc.uchicago.edu Nikolai N. Khodarev, email: n-khodarev@uchicago.edu Keywords: ionizing radiation, DNA damage, small non-coding RNAs, Type I interferon, RIG-I-like receptor (RLR) Received: February 27, 2016 Accepted: March 05, 2016 Published: March 28, 2016 ABSTRACT Emerging evidence indicates that ionizing radiation (IR) and chemotherapy activate Type I interferon (IFN) signaling in tumor and host cells. However, the mechanism of induction is poorly understood. We identified a novel radioprotective role for the DEXH box RNA helicase LGP2 ( DHX58 ) through its suppression of IR-induced cytotoxic IFN-beta [ 1 ]. LGP2 inhibits activation of the RIG-I-like receptor (RLR) pathway upon binding of viral RNA to the cytoplasmic sensors RIG-I ( DDX58 ) and MDA5 ( IFIH1 ) and subsequent IFN signaling via the mitochondrial adaptor protein MAVS ( IPS1 ). Here we show that MAVS is necessary for IFN-beta induction and interferon-stimulated gene expression in the response to IR. Suppression of MAVS conferred radioresistance in normal and cancer cells. Germline deletion of RIG-I, but not MDA5, protected mice from death following total body irradiation, while deletion of LGP2 accelerated the death of irradiated animals. In human tumors depletion of RIG-I conferred resistance to IR and different classes of chemotherapy drugs. Mechanistically, IR stimulated the binding of cytoplasmic RIG-I with small endogenous non-coding RNAs (sncRNAs), which triggered IFN-beta activity. We demonstrate that the small nuclear RNAs U1 and U2 translocate to the cytoplasm after IR treatment, thus stimulating the formation of RIG-I: RNA complexes and initiating downstream signaling events. Taken together, these findings suggest that the physiologic responses to radio-/chemo-therapy converge on an antiviral program in recruitment of the RLR pathway by a sncRNA-dependent activation of RIG-I which commences cytotoxic IFN signaling. Importantly, activation of interferon genes by radiation or chemotherapy is associated with a favorable outcome in patients undergoing treatment for cancer. To our knowledge, this is the first demonstration of a cell-intrinsic response to clinically relevant genotoxic treatments mediated by an RNA-dependent mechanism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.8420

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 183

Metadata

Authors
Ranoa, D. R. E., Parekh, A. D., Pitroda, S. P., Huang, X., Darga, T., Wong, A. C., Huang, L., Andrade, J., Staley, J. P., Satoh, T., Akira, S., Weichselbaum, R. R., & Khodarev, N. N.
Venue
Oncotarget
Published
2016-03-28
Volume
7
Issue
18
Pages
26496-26515
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2315627085
Cited by
183
References
13
FWCI
10.26
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs. https://app.cochat.ai/papers/10.18632/oncotarget.8420
The paper
Ranoa, D. R. E., Parekh, A. D., Pitroda, S. P., Huang, X., Darga, T., Wong, A. C., Huang, L., Andrade, J., Staley, J. P., Satoh, T., Akira, S., Weichselbaum, R. R., & Khodarev, N. N. (2016). Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs. Oncotarget. https://doi.org/10.18632/oncotarget.8420

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.